.Nature Medication, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medicine conjugate (ADC) tisotumab vedotin caused improved progression-free and also total survival, resulting in FDA approval as well as a new therapy possibility for patients.